Skytrofa (previously Lonapegsomatropin Ascendis Pharma) Európai Unió - magyar - EMA (European Medicines Agency)

skytrofa (previously lonapegsomatropin ascendis pharma)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hipofízis és hypothalamus hormonok és analógok - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.

Ngenla Európai Unió - magyar - EMA (European Medicines Agency)

ngenla

pfizer europe ma eeig - somatrogon - growth and development - agyalapi mirigy, vagy a hypothalamus hormonok, analÓgokkal - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.